Literature DB >> 27422112

Low-Grade Serous Carcinoma of the Ovary.

Rachel N Grisham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27422112

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  5 in total

1.  Phase Ib Study of Binimetinib with Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer: Final Results, Potential Biomarkers, and Extreme Responders.

Authors:  Rachel N Grisham; Kathleen N Moore; Michael S Gordon; Wael Harb; Gwendolyn Cody; Darragh F Halpenny; Vicky Makker; Carol A Aghajanian
Journal:  Clin Cancer Res       Date:  2018-05-29       Impact factor: 12.531

2.  BRAFV600E mutations and immunohistochemical expression of VE1 protein in low-grade serous neoplasms of the ovary.

Authors:  Gulisa Turashvili; Rachel N Grisham; Sarah Chiang; Deborah F DeLair; Kay J Park; Robert A Soslow; Rajmohan Murali
Journal:  Histopathology       Date:  2018-06-22       Impact factor: 5.087

Review 3.  Low-Grade Serous Ovarian Cancer: Current Treatment Paradigms and Future Directions.

Authors:  Rachel N Grisham; Gopa Iyer
Journal:  Curr Treat Options Oncol       Date:  2018-09-18

4.  FAM83D promotes ovarian cancer progression and its potential application in diagnosis of invasive ovarian cancer.

Authors:  Qingyu Zhang; Shan Yu; Samson Ian Sam Lok; Alice Sze Tsai Wong; Yufei Jiao; Leo Tsz On Lee
Journal:  J Cell Mol Med       Date:  2019-04-30       Impact factor: 5.310

Review 5.  New Predictive Biomarkers for Ovarian Cancer.

Authors:  Ghofraan Abdulsalam Atallah; Nor Haslinda Abd Aziz; Chew Kah Teik; Mohamad Nasir Shafiee; Nirmala Chandralega Kampan
Journal:  Diagnostics (Basel)       Date:  2021-03-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.